Natalie Sikes
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Natalie Sikes' research focuses on clinical outcomes for extremely preterm infants. Her work has investigated the impact of interventions such as erythropoietin and iron supplementation on short- and long-term health consequences, including kidney outcomes, neurodevelopmental trajectories, and mortality. Sikes has published findings related to the association between brain magnetic resonance imaging and 2-year outcomes, as well as the effects of mode of delivery on brain injury and mortality in extremely low birth weight infants. Her research utilizes data from clinical trials, such as the Preterm Erythropoietin Neuroprotection Trial (PENUT), and retrospective analyses of patient cohorts. Sikes' publications also include studies on the predictive value of aEEG for intracranial hemorrhage and the association between urinary biomarkers and chronic kidney disease in this vulnerable population.
Metrics
- h-index: 7
- Publications: 9
- Citations: 194
Selected Publications
-
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates (2023)
-
Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns (2022)
-
Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial (2021)
-
Low-Voltage aEEG as Predictor of Intracranial Hemorrhage in Preterm Infants (2011)
Collaboration Network
Top Collaborators
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Similar Researchers
Based on overlapping research topics